Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: A multicenter study

Seth D. Crockett, Isaac M. Lipkus, Stephanie D. Bright, Richard E. Sampliner, Kenneth Ke Ning Wang, Vikram Boolchand, Lori S. Lutzke, Nicholas J. Shaheen

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Guidelines suggest that patients with nondysplastic Barrett's esophagus (BE) undergo endoscopic surveillance every 3 to 5 years, but actual use of surveillance endoscopy and the determinants of variation in surveillance intervals are not known. To measure use of surveillance endoscopy and its variation in patients with nondysplastic BE. Multicenter, cross-sectional study. Three sites in Arizona, Minnesota, and North Carolina. This study involved patients who had prevalent BE without a history of high-grade dysplasia or esophageal adenocarcinoma. Participants were given validated measures of quality of life, numeracy, and cancer risk perception, and the total number of prior endoscopic surveillance examinations was measured. Oversurveillance was defined as >1 surveillance examination per 3-year period. Among 235 patients with nondysplastic BE, 76% were male and 94% were white. The average (± standard deviation [SD]) duration of BE was 6.5 ± 5.9 years. The mean (± SD) number of endoscopies per 3-year period was 2.7 ± 2.6. Oversurveillance was present in 65% of participants, resulting in a mean of 2.3 excess endoscopies per patient. Neither numeracy skills nor patient perception of cancer risk were associated with oversurveillance. Endoscopies were measured by patient report, which is subject to error. Results may be generalizable only to patients seen in academic centers. Most patients with nondysplastic BE had more surveillance endoscopic examinations than is recommended by published guidelines. Patient factors did not predict oversurveillance, indicating that other factors may influence decisions about the interval and frequency of surveillance examinations.

Original languageEnglish (US)
JournalGastrointestinal Endoscopy
Volume75
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Barrett Esophagus
Multicenter Studies
Endoscopy
Guidelines
Neoplasms
Adenocarcinoma
Cross-Sectional Studies
Quality of Life

ASJC Scopus subject areas

  • Gastroenterology
  • Radiology Nuclear Medicine and imaging

Cite this

Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus : A multicenter study. / Crockett, Seth D.; Lipkus, Isaac M.; Bright, Stephanie D.; Sampliner, Richard E.; Wang, Kenneth Ke Ning; Boolchand, Vikram; Lutzke, Lori S.; Shaheen, Nicholas J.

In: Gastrointestinal Endoscopy, Vol. 75, No. 1, 01.2012.

Research output: Contribution to journalArticle

Crockett, SD, Lipkus, IM, Bright, SD, Sampliner, RE, Wang, KKN, Boolchand, V, Lutzke, LS & Shaheen, NJ 2012, 'Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: A multicenter study', Gastrointestinal Endoscopy, vol. 75, no. 1. https://doi.org/10.1016/j.gie.2011.08.042
Crockett, Seth D. ; Lipkus, Isaac M. ; Bright, Stephanie D. ; Sampliner, Richard E. ; Wang, Kenneth Ke Ning ; Boolchand, Vikram ; Lutzke, Lori S. ; Shaheen, Nicholas J. / Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus : A multicenter study. In: Gastrointestinal Endoscopy. 2012 ; Vol. 75, No. 1.
@article{6380aa2b2de04524a04eaa360755af29,
title = "Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: A multicenter study",
abstract = "Guidelines suggest that patients with nondysplastic Barrett's esophagus (BE) undergo endoscopic surveillance every 3 to 5 years, but actual use of surveillance endoscopy and the determinants of variation in surveillance intervals are not known. To measure use of surveillance endoscopy and its variation in patients with nondysplastic BE. Multicenter, cross-sectional study. Three sites in Arizona, Minnesota, and North Carolina. This study involved patients who had prevalent BE without a history of high-grade dysplasia or esophageal adenocarcinoma. Participants were given validated measures of quality of life, numeracy, and cancer risk perception, and the total number of prior endoscopic surveillance examinations was measured. Oversurveillance was defined as >1 surveillance examination per 3-year period. Among 235 patients with nondysplastic BE, 76{\%} were male and 94{\%} were white. The average (± standard deviation [SD]) duration of BE was 6.5 ± 5.9 years. The mean (± SD) number of endoscopies per 3-year period was 2.7 ± 2.6. Oversurveillance was present in 65{\%} of participants, resulting in a mean of 2.3 excess endoscopies per patient. Neither numeracy skills nor patient perception of cancer risk were associated with oversurveillance. Endoscopies were measured by patient report, which is subject to error. Results may be generalizable only to patients seen in academic centers. Most patients with nondysplastic BE had more surveillance endoscopic examinations than is recommended by published guidelines. Patient factors did not predict oversurveillance, indicating that other factors may influence decisions about the interval and frequency of surveillance examinations.",
author = "Crockett, {Seth D.} and Lipkus, {Isaac M.} and Bright, {Stephanie D.} and Sampliner, {Richard E.} and Wang, {Kenneth Ke Ning} and Vikram Boolchand and Lutzke, {Lori S.} and Shaheen, {Nicholas J.}",
year = "2012",
month = "1",
doi = "10.1016/j.gie.2011.08.042",
language = "English (US)",
volume = "75",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus

T2 - A multicenter study

AU - Crockett, Seth D.

AU - Lipkus, Isaac M.

AU - Bright, Stephanie D.

AU - Sampliner, Richard E.

AU - Wang, Kenneth Ke Ning

AU - Boolchand, Vikram

AU - Lutzke, Lori S.

AU - Shaheen, Nicholas J.

PY - 2012/1

Y1 - 2012/1

N2 - Guidelines suggest that patients with nondysplastic Barrett's esophagus (BE) undergo endoscopic surveillance every 3 to 5 years, but actual use of surveillance endoscopy and the determinants of variation in surveillance intervals are not known. To measure use of surveillance endoscopy and its variation in patients with nondysplastic BE. Multicenter, cross-sectional study. Three sites in Arizona, Minnesota, and North Carolina. This study involved patients who had prevalent BE without a history of high-grade dysplasia or esophageal adenocarcinoma. Participants were given validated measures of quality of life, numeracy, and cancer risk perception, and the total number of prior endoscopic surveillance examinations was measured. Oversurveillance was defined as >1 surveillance examination per 3-year period. Among 235 patients with nondysplastic BE, 76% were male and 94% were white. The average (± standard deviation [SD]) duration of BE was 6.5 ± 5.9 years. The mean (± SD) number of endoscopies per 3-year period was 2.7 ± 2.6. Oversurveillance was present in 65% of participants, resulting in a mean of 2.3 excess endoscopies per patient. Neither numeracy skills nor patient perception of cancer risk were associated with oversurveillance. Endoscopies were measured by patient report, which is subject to error. Results may be generalizable only to patients seen in academic centers. Most patients with nondysplastic BE had more surveillance endoscopic examinations than is recommended by published guidelines. Patient factors did not predict oversurveillance, indicating that other factors may influence decisions about the interval and frequency of surveillance examinations.

AB - Guidelines suggest that patients with nondysplastic Barrett's esophagus (BE) undergo endoscopic surveillance every 3 to 5 years, but actual use of surveillance endoscopy and the determinants of variation in surveillance intervals are not known. To measure use of surveillance endoscopy and its variation in patients with nondysplastic BE. Multicenter, cross-sectional study. Three sites in Arizona, Minnesota, and North Carolina. This study involved patients who had prevalent BE without a history of high-grade dysplasia or esophageal adenocarcinoma. Participants were given validated measures of quality of life, numeracy, and cancer risk perception, and the total number of prior endoscopic surveillance examinations was measured. Oversurveillance was defined as >1 surveillance examination per 3-year period. Among 235 patients with nondysplastic BE, 76% were male and 94% were white. The average (± standard deviation [SD]) duration of BE was 6.5 ± 5.9 years. The mean (± SD) number of endoscopies per 3-year period was 2.7 ± 2.6. Oversurveillance was present in 65% of participants, resulting in a mean of 2.3 excess endoscopies per patient. Neither numeracy skills nor patient perception of cancer risk were associated with oversurveillance. Endoscopies were measured by patient report, which is subject to error. Results may be generalizable only to patients seen in academic centers. Most patients with nondysplastic BE had more surveillance endoscopic examinations than is recommended by published guidelines. Patient factors did not predict oversurveillance, indicating that other factors may influence decisions about the interval and frequency of surveillance examinations.

UR - http://www.scopus.com/inward/record.url?scp=84855198653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855198653&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2011.08.042

DO - 10.1016/j.gie.2011.08.042

M3 - Article

C2 - 22100301

AN - SCOPUS:84855198653

VL - 75

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 1

ER -